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Background: The utility of saliva as an alternative diagnostic fluid for identifying biomarkers of acute myocardial infarction (AMI) was investigated. The 
goal was to determine if salivary biomarkers could help facilitate an earlier screening diagnosis of AMI, especially in cases of non-ST elevation MI.
Methods: Serum and unstimulated whole saliva (UWS) obtained from 80 AMI patients within 48 hours of chest pain onset and 85 asymptomatic 
healthy controls were assayed for 21 proteins relevant to cardiovascular disease using Beadlyte technology (Luminex®) and enzyme immunoassays. 
Data were analyzed using concentration cutpoints, electrocardiograph findings, and classification and regression tree (CART) to determine the ability 
of each biomarker, or combinations of biomarkers, to screen for AMI.
Results: Virtually all biomarkers were detectable in UWS, with unique profiles appearing in the serum and UWS of AMI cases. Median UWS levels 
of C-reactive protein (CRP), soluble CD40 ligand (sCD40L), myeloperoxidase, myoglobin, tumor necrosis factor-, soluble intercellular adhesion 
molecule-1 and matrix metalloproteinase 9 were significantly different between the AMI cases and the controls (p < 0.05). CART analysis resulted 
in a decision tree composed of UWS CRP, UWS sCD40L and UWS creatine kinase MB fraction that yielded a sensitivity of 86%, specificity of 81%, 
positive predictive value of 81% and negative predictive value of 86% for diagnosing AMI.
Conclusions: Application of CART analysis demonstrates that salivary biomarker measurements used in the absence of electrocardiograph findings 
confer a high degree of sensitivity and specificity for the identification of AMI. Thus, saliva-based tests may provide additional important diagnostic 
screening information for patients with chest pain at risk for having an AMI. Supported by U01 DE017793 from the NIDCR.
